The ASX is one of the larger stock exchanges of the world, but it’s important to remember that it’s the sum of its constituents.
There has been a recent bout of takeovers announced by overseas entities which will acquire ASX-listed businesses.
Some of the most notable takeovers are that Westfield Corp Ltd (ASX: WFD) is being taken over by Unibail-Rodamco, Mantra Group Ltd (ASX: MTR) is being taken over by AccorHotels, Aconex Ltd (ASX: ACX) is being taken over by Oracle and TRILOGYINT FPO NZX (ASX: TIL) has an offer from CITIC Capital.
These acquisitions are nice for shareholders of those businesses, they get a big pay out for their shares and can then do whatever they like with the cash.
However, I don’t think it’s good news for the ASX, particularly over the long-term. These businesses are important to the ASX, they offer diversification and potential growth. Whereas now it will be a foreign entity that reaps the benefits of the infrastructure boom instead of shareholders of Aconex and the other businesses that are getting taken over.
Investors who have their money in ASX index products will be worse off over the long-term without the growth that could have been generated.
The weakening Australian dollar and relatively small stock exchange means that ASX businesses look like tasty acquisition targets for overseas predators.
Shareholders who are lucky enough to have had a takeover offer would be wise to re-invest the cash back into more shares. Index funds like Vanguard MSCI Index International Shares ETF (ASX: VGS) and BETANASDAQ ETF UNITS (ASX: NDQ) or a top quality share like Ramsay Health Care Limited (ASX: RHC) would be good choices.
The best place to redeploy your cash could be these growth shares.
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor Tristan Harrison owns shares of Ramsay Health Care Limited and TRILOGYINT FPO NZX. The Motley Fool Australia owns shares of and has recommended ACONEX FPO, TRILOGYINT FPO NZX and BETANASDAQ ETF UNITS. The Motley Fool Australia has recommended Ramsay Health Care Limited, TRILOGYINT FPO NZX, Vanguard MSCI Index International Shares ETF, and Westfield. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.